Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.56 |
| ▸ | DRD1 | P21728 | 2/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.48 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 2/20 | 0.43 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 6/20 | 0.41 |
| ▸ | PPARA | Q07869 | 5/20 | 0.41 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL317872 | 0.94 | ST14 (0.50) | HRH3DRD1ST14SLC6A4MAOB | |
| SCHEMBL13264261 | 0.82 | DRD1 (0.68) | DRD1SLC6A4PPARGPPARADAGLA | |
| SCHEMBL21816553 | 0.80 | RAB9A (0.43) | DRD1SLC6A4 | |
| SCHEMBL9061966 | 0.80 | DRD1 (0.52) | DRD1PPARGPPARADAGLALMNA | |
| SCHEMBL3640668 | 0.78 | TAAR1 (0.55) | TAAR1MAOB | |
| SCHEMBL8379956 | 0.77 | DRD1 (0.49) | DRD1MAOBPPARGPPARADAGLA | |
| SCHEMBL3536741 | 0.77 | DRD1 (0.57) | DRD1TAAR1SLC6A4LMNA | |
| SCHEMBL28006451 | 0.76 | ST14 (0.74) | HRH3TAAR1ST14MAOBLOXL2 | |
| Hydrochloric Acid SCHEMBL4503674 | 0.76 | TAAR1 (0.53) | TAAR1MAOB | |
| SCHEMBL2027893 | 0.76 | ST14 (0.45) | HRH3ST14MAOBLOXL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050085524-A1 | Pyrazolecarboxamides, intermediates therefor and pest control agent comprising the same as active ingredients | NIHON NOHYAKU CO,. LTD. (JP) | 2005-04-21 | — | — | US | disclosed |
| CN-1511142-A | Pyrazole amide derivative, intermediate for producing the same, and pest control agent containing the same as active ingredient | 日本农药株式会社 | 2004-07-07 | — | — | CN | disclosed |
| EP-1384714-A1 | PYRAZOLECARBOXAMIDE DERIVATIVE, INTERMEDIATE THEREFOR, AND PEST CONTROL AGENT CONTAINING THE SAME AS ACTIVE INGREDIENT | Nihon Nohyaku Co., Ltd. (JP) | 2004-01-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050085524-A1 | Pyrazolecarboxamides, intermediates therefor and pest control agent comprising the same as active ingredients | NOTUM, CYP51A1, CBR3 | HRH3 204/4885DRD1 1164/4885TAAR1 2300/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.